A comparison of vaginal misoprostol versus vaginal misoprostol and nitric oxide donor for termination of pregnancy at 13 to 29 weeks. A prospective randomised trial

Completed

• Conditions: Obstetrics and gynaecology; Pregnancy and Childbirth; Medical abortion

• Registration Number: ISRCTN44341343
• Lead Sponsor: Farhat Hached University Teaching Hospital (Tunisia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2002-12-16
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

1. All patients requiring a termination of pregnancy between 13 and 29 weeks of gestation
2. No pregnancy induced hypertension
3. No pre-eclampsia
4. No vaginal bleeding
5. Cervix dilated less then 2 cm
6. No vaginal bleeding
7. At admission blood pressure: systolic >120 mmHg; diastolic >80 mmHg

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified